• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD

ZELIRA THERAPEUTICS LIMITED - Announcements

7.32% ! 38.0¢
Market Cap $4.520M  !

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements



ZLD Trading HaltPRICE SENSITIVE19/10/21 download Created with Sketch. 317.01KB
ZLD Notification of cessation of securities - ZLD14/10/21 download Created with Sketch. 22.28KB
ZLD Notification of Expiry of Unlisted Options14/10/21 download Created with Sketch. 309.63KB
ZLD Change of Director's Interest Notice01/10/21 download Created with Sketch. 266.78KB
ZLD Annual Report to shareholders30/09/21 download Created with Sketch. 15.21MB
ZLD Zelira Launches RAF FIVE Acne Treatment ProductsPRICE SENSITIVE23/09/21 download Created with Sketch. 3.69MB
ZLD Zelira enters Germany via Exclusive Distribution AgreementPRICE SENSITIVE20/09/21 download Created with Sketch. 1.52MB
ZLD Appendix 4G30/08/21 download Created with Sketch. 344.12KB
ZLD Appendix 4E and Financial Report to ShareholdersPRICE SENSITIVE30/08/21 download Created with Sketch. 1.15MB
ZLD Notification of cessation of securities - ZLD23/08/21 download Created with Sketch. 21.72KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/21 download Created with Sketch. 155.52KB
ZLD June 2021 Quarterly Activities ReportPRICE SENSITIVE30/07/21 download Created with Sketch. 578.95KB
ZLD US Observational Clinical Pain Trial Receives IRB ApprovalPRICE SENSITIVE12/07/21 download Created with Sketch. 217.81KB
ZLD Pershing trading restrictions for cannabis companies lifted05/07/21 download Created with Sketch. 209.38KB
ZLD Cantor Fitzgerald - Investor PresentationPRICE SENSITIVE30/06/21 download Created with Sketch. 3.88MB
ZLD ZLD to present at Cantor Fitzgerald International Conference25/06/21 download Created with Sketch. 215.24KB
ZLD Clinical trial results of Zenivol published in SLEEP21/06/21 download Created with Sketch. 250.32KB
ZLD Research Demonstrates Significant Uptake of CBD Into BrainPRICE SENSITIVE18/06/21 download Created with Sketch. 260.31KB
ZLD Zelira to Launch CBD Toothpaste in the United KingdomPRICE SENSITIVE15/06/21 download Created with Sketch. 163.18KB
ZLD HHI: Expands ZLDs Distribution Agreement with CBD Toothpaste15/06/21 download Created with Sketch. 192.44KB
ZLD ZLD and Levin Health to Conduct Chronic Pain Clinical TrialPRICE SENSITIVE03/06/21 download Created with Sketch. 189.07KB
ZLD Final Director's Interest Notice17/05/21 download Created with Sketch. 198.63KB
ZLD Zeliras HOPE Range of Products Launches in Washington DCPRICE SENSITIVE06/05/21 download Created with Sketch. 155.24KB
ZLD Change of Company Address27/04/21 download Created with Sketch. 121.75KB
ZLD March 2021 Quarterly ReportPRICE SENSITIVE21/04/21 download Created with Sketch. 191.43KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE21/04/21 download Created with Sketch. 156.1KB
ZLD Zelira Announces Record Third Quarter RevenuePRICE SENSITIVE15/04/21 download Created with Sketch. 176.22KB
ZLD Cleansing Notice and Appendix 2A23/02/21 download Created with Sketch. 291.77KB
ZLD Appendix 4D & FY21 Interim Financial ReportPRICE SENSITIVE22/02/21 download Created with Sketch. 857.75KB
ZLD Strategic Transition and Executive ChangesPRICE SENSITIVE15/02/21 download Created with Sketch. 154.8KB
ZLD US National Cannabis Roundtable appoints Zelira as Director11/02/21 download Created with Sketch. 171.03KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE29/01/21 download Created with Sketch. 155.7KB
ZLD December 2020 Quarterly ReportPRICE SENSITIVE29/01/21 download Created with Sketch. 169.32KB
ZLD Appendix 3G20/01/21 download Created with Sketch. 323.13KB
ZLD Issue of Unquoted Options20/01/21 download Created with Sketch. 147.84KB
ZLD Clarification regarding HOPE Distribution to Washington DC18/12/20 download Created with Sketch. 167.81KB
ZLD Zelira Expands HOPE Distribution to Washington DC, USAPRICE SENSITIVE14/12/20 download Created with Sketch. 172.6KB
ZLD Change of Director's Interest Notice11/12/20 download Created with Sketch. 201.77KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE11/12/20 download Created with Sketch. 167.46KB
ZLD ZLD Partners with SprinJene to Launch CBD Toothpaste in USPRICE SENSITIVE02/12/20 download Created with Sketch. 229.28KB
ZLD Cancellation of Unlisted Options20/11/20 download Created with Sketch. 148.96KB
ZLD Appendix 3G13/11/20 download Created with Sketch. 322.14KB
ZLD Results of Meeting13/11/20 download Created with Sketch. 223.5KB
ZLD EMD:Emyria Enters Data Deal with ZLD to Support Autism TrialPRICE SENSITIVE09/11/20 download Created with Sketch. 242.2KB
ZLD Emyria Deal and Autism Observational Trial for HOPE ProductsPRICE SENSITIVE09/11/20 download Created with Sketch. 253.16KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/10/20 download Created with Sketch. 155.37KB
ZLD September 2020 Quarterly ReportPRICE SENSITIVE30/10/20 download Created with Sketch. 170.75KB
ZLD HOPE launches in Australia after TGA approves releasePRICE SENSITIVE27/10/20 download Created with Sketch. 179.34KB
ZLD Updated Investor Presentation - Non-Deal Roadshow22/10/20 download Created with Sketch. 1.95MB
ZLD Cleansing Notice and Appendix 2A16/10/20 download Created with Sketch. 472.42KB
ZLD Notice of Annual General Meeting12/10/20 download Created with Sketch. 262.4KB
ZLD Letter to Shareholders re Upcoming Annual General Meeting12/10/20 download Created with Sketch. 167.06KB
ZLD ZLD Signs Real-World Data Agreement for Zenivol with Emyria30/09/20 download Created with Sketch. 229.95KB
ZLD Becoming a substantial holder - Tiga Trading Pty Ltd28/09/20 download Created with Sketch. 150.96KB
ZLD Cleansing Notice and Appendix 2A25/09/20 download Created with Sketch. 472.46KB
ZLD Appendix 3G25/09/20 download Created with Sketch. 320.12KB
ZLD Proposed issue of Securities - ZLD23/09/20 download Created with Sketch. 28.59KB
ZLD Thorney Becomes a Substantial Strategic Investor in ZeliraPRICE SENSITIVE23/09/20 download Created with Sketch. 200.02KB
ZLD Results of Meeting17/09/20 download Created with Sketch. 216.29KB
ZLD Zenivol launches in Australia after TGA approves releasePRICE SENSITIVE16/09/20 download Created with Sketch. 201.99KB
ZLD Appendix 3G11/09/20 download Created with Sketch. 320.83KB
ZLD Issue of Unquoted Options11/09/20 download Created with Sketch. 147.02KB
ZLD Zelira Presentation ASX Small and Mid-Cap Conference10/09/20 download Created with Sketch. 4.32MB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USAPRICE SENSITIVE08/09/20 download Created with Sketch. 195.96KB
ZLD Appendix 4G28/08/20 download Created with Sketch. 162.16KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE28/08/20 download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In LouisianaPRICE SENSITIVE20/08/20 download Created with Sketch. 180.23KB
ZLD Ceasing to be a substantial holder14/08/20 download Created with Sketch. 230.2KB
ZLD Change in substantial holding14/08/20 download Created with Sketch. 160.53KB
ZLD Change of Director's Interest Notice x214/08/20 download Created with Sketch. 252.52KB
ZLD Notice of General Meeting13/08/20 download Created with Sketch. 201.07KB
ZLD Letter to Shareholders re Upcoming General Meeting13/08/20 download Created with Sketch. 167.25KB
ZLD Appendix 3G11/08/20 download Created with Sketch. 319.74KB
ZLD Cleansing Notice and Appendix 2A11/08/20 download Created with Sketch. 601.79KB
ZLD Proposed issue of Securities - ZLD03/08/20 download Created with Sketch. 25.16KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed PlacementPRICE SENSITIVE03/08/20 download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly ReportPRICE SENSITIVE30/07/20 download Created with Sketch. 245.26KB
ZLD Trading HaltPRICE SENSITIVE29/07/20 download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular DiseasesPRICE SENSITIVE22/07/20 download Created with Sketch. 224.23KB
ZLD Results of Meeting21/07/20 download Created with Sketch. 254.05KB
ZLD Trading HaltPRICE SENSITIVE20/07/20 download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical EndpointsPRICE SENSITIVE14/07/20 download Created with Sketch. 288.01KB
ZLD Proposed issue of Securities - ZLD10/07/20 download Created with Sketch. 25.61KB
ZLD Director Performance Rights10/07/20 download Created with Sketch. 152.67KB
ZLD Investor Presentation - Non-deal Roadshow09/07/20 download Created with Sketch. 4.84MB
ZLD Proposed issue of Securities - ZLD17/06/20 download Created with Sketch. 41.3KB
ZLD Notice of General Meeting17/06/20 download Created with Sketch. 307.1KB
ZLD Letter to Shareholders17/06/20 download Created with Sketch. 166.56KB
ZLD ZLD to form partnership for chronic pain in retired athletes17/06/20 download Created with Sketch. 233.21KB
ZLD Finalisation of Appointment Details - Managing Director, USA03/06/20 download Created with Sketch. 198.17KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE productsPRICE SENSITIVE26/05/20 download Created with Sketch. 155.63KB
ZLD Investor Presentation - Non-deal Roadshow01/05/20 download Created with Sketch. 5.08MB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly ReportPRICE SENSITIVE30/04/20 download Created with Sketch. 162.06KB
ZLD Insomnia Phase 2 Clinical Trial Presentation08/04/20 download Created with Sketch. 3.09MB
ZLD Zelira Therapeutics Insomnia Clinical Trial Media Release07/04/20 download Created with Sketch. 307.83KB
ZLD Insomnia Trial Meets Primary and Secondary EndpointsPRICE SENSITIVE07/04/20 download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 995.62KB
ZLD EMD: EMD to Conduct Opioid Sparing Clinical Trial for Zelira27/02/20 download Created with Sketch. 195.36KB
ZLD Trading Halt
19/10/21PRICE SENSITIVE download Created with Sketch. 317.01KB
ZLD Notification of cessation of securities - ZLD
14/10/21 download Created with Sketch. 22.28KB
ZLD Notification of Expiry of Unlisted Options
14/10/21 download Created with Sketch. 309.63KB
ZLD Change of Director's Interest Notice
01/10/21 download Created with Sketch. 266.78KB
ZLD Annual Report to shareholders
30/09/21 download Created with Sketch. 15.21MB
ZLD Zelira Launches RAF FIVE Acne Treatment Products
23/09/21PRICE SENSITIVE download Created with Sketch. 3.69MB
ZLD Zelira enters Germany via Exclusive Distribution Agreement
20/09/21PRICE SENSITIVE download Created with Sketch. 1.52MB
ZLD Appendix 4G
30/08/21 download Created with Sketch. 344.12KB
ZLD Appendix 4E and Financial Report to Shareholders
30/08/21PRICE SENSITIVE download Created with Sketch. 1.15MB
ZLD Notification of cessation of securities - ZLD
23/08/21 download Created with Sketch. 21.72KB
ZLD Appendix 4C - quarterly
30/07/21PRICE SENSITIVE download Created with Sketch. 155.52KB
ZLD June 2021 Quarterly Activities Report
30/07/21PRICE SENSITIVE download Created with Sketch. 578.95KB
ZLD US Observational Clinical Pain Trial Receives IRB Approval
12/07/21PRICE SENSITIVE download Created with Sketch. 217.81KB
ZLD Pershing trading restrictions for cannabis companies lifted
05/07/21 download Created with Sketch. 209.38KB
ZLD Cantor Fitzgerald - Investor Presentation
30/06/21PRICE SENSITIVE download Created with Sketch. 3.88MB
ZLD ZLD to present at Cantor Fitzgerald International Conference
25/06/21 download Created with Sketch. 215.24KB
ZLD Clinical trial results of Zenivol published in SLEEP
21/06/21 download Created with Sketch. 250.32KB
ZLD Research Demonstrates Significant Uptake of CBD Into Brain
18/06/21PRICE SENSITIVE download Created with Sketch. 260.31KB
ZLD Zelira to Launch CBD Toothpaste in the United Kingdom
15/06/21PRICE SENSITIVE download Created with Sketch. 163.18KB
ZLD HHI: Expands ZLDs Distribution Agreement with CBD Toothpaste
15/06/21 download Created with Sketch. 192.44KB
ZLD ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
03/06/21PRICE SENSITIVE download Created with Sketch. 189.07KB
ZLD Final Director's Interest Notice
17/05/21 download Created with Sketch. 198.63KB
ZLD Zeliras HOPE Range of Products Launches in Washington DC
06/05/21PRICE SENSITIVE download Created with Sketch. 155.24KB
ZLD Change of Company Address
27/04/21 download Created with Sketch. 121.75KB
ZLD March 2021 Quarterly Report
21/04/21PRICE SENSITIVE download Created with Sketch. 191.43KB
ZLD Appendix 4C - quarterly
21/04/21PRICE SENSITIVE download Created with Sketch. 156.1KB
ZLD Zelira Announces Record Third Quarter Revenue
15/04/21PRICE SENSITIVE download Created with Sketch. 176.22KB
ZLD Cleansing Notice and Appendix 2A
23/02/21 download Created with Sketch. 291.77KB
ZLD Appendix 4D & FY21 Interim Financial Report
22/02/21PRICE SENSITIVE download Created with Sketch. 857.75KB
ZLD Strategic Transition and Executive Changes
15/02/21PRICE SENSITIVE download Created with Sketch. 154.8KB
ZLD US National Cannabis Roundtable appoints Zelira as Director
11/02/21 download Created with Sketch. 171.03KB
ZLD Appendix 4C - quarterly
29/01/21PRICE SENSITIVE download Created with Sketch. 155.7KB
ZLD December 2020 Quarterly Report
29/01/21PRICE SENSITIVE download Created with Sketch. 169.32KB
ZLD Appendix 3G
20/01/21 download Created with Sketch. 323.13KB
ZLD Issue of Unquoted Options
20/01/21 download Created with Sketch. 147.84KB
ZLD Clarification regarding HOPE Distribution to Washington DC
18/12/20 download Created with Sketch. 167.81KB
ZLD Zelira Expands HOPE Distribution to Washington DC, USA
14/12/20PRICE SENSITIVE download Created with Sketch. 172.6KB
ZLD Change of Director's Interest Notice
11/12/20 download Created with Sketch. 201.77KB
ZLD R&D Tax Incentive Refund
11/12/20PRICE SENSITIVE download Created with Sketch. 167.46KB
ZLD ZLD Partners with SprinJene to Launch CBD Toothpaste in US
02/12/20PRICE SENSITIVE download Created with Sketch. 229.28KB
ZLD Cancellation of Unlisted Options
20/11/20 download Created with Sketch. 148.96KB
ZLD Appendix 3G
13/11/20 download Created with Sketch. 322.14KB
ZLD Results of Meeting
13/11/20 download Created with Sketch. 223.5KB
ZLD EMD:Emyria Enters Data Deal with ZLD to Support Autism Trial
09/11/20PRICE SENSITIVE download Created with Sketch. 242.2KB
ZLD Emyria Deal and Autism Observational Trial for HOPE Products
09/11/20PRICE SENSITIVE download Created with Sketch. 253.16KB
ZLD Appendix 4C - quarterly
30/10/20PRICE SENSITIVE download Created with Sketch. 155.37KB
ZLD September 2020 Quarterly Report
30/10/20PRICE SENSITIVE download Created with Sketch. 170.75KB
ZLD HOPE launches in Australia after TGA approves release
27/10/20PRICE SENSITIVE download Created with Sketch. 179.34KB
ZLD Updated Investor Presentation - Non-Deal Roadshow
22/10/20 download Created with Sketch. 1.95MB
ZLD Cleansing Notice and Appendix 2A
16/10/20 download Created with Sketch. 472.42KB
ZLD Notice of Annual General Meeting
12/10/20 download Created with Sketch. 262.4KB
ZLD Letter to Shareholders re Upcoming Annual General Meeting
12/10/20 download Created with Sketch. 167.06KB
ZLD ZLD Signs Real-World Data Agreement for Zenivol with Emyria
30/09/20 download Created with Sketch. 229.95KB
ZLD Becoming a substantial holder - Tiga Trading Pty Ltd
28/09/20 download Created with Sketch. 150.96KB
ZLD Cleansing Notice and Appendix 2A
25/09/20 download Created with Sketch. 472.46KB
ZLD Appendix 3G
25/09/20 download Created with Sketch. 320.12KB
ZLD Proposed issue of Securities - ZLD
23/09/20 download Created with Sketch. 28.59KB
ZLD Thorney Becomes a Substantial Strategic Investor in Zelira
23/09/20PRICE SENSITIVE download Created with Sketch. 200.02KB
ZLD Results of Meeting
17/09/20 download Created with Sketch. 216.29KB
ZLD Zenivol launches in Australia after TGA approves release
16/09/20PRICE SENSITIVE download Created with Sketch. 201.99KB
ZLD Appendix 3G
11/09/20 download Created with Sketch. 320.83KB
ZLD Issue of Unquoted Options
11/09/20 download Created with Sketch. 147.02KB
ZLD Zelira Presentation ASX Small and Mid-Cap Conference
10/09/20 download Created with Sketch. 4.32MB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USA
08/09/20PRICE SENSITIVE download Created with Sketch. 195.96KB
ZLD Appendix 4G
28/08/20 download Created with Sketch. 162.16KB
ZLD Appendix 4E & Financial Statements
28/08/20PRICE SENSITIVE download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In Louisiana
20/08/20PRICE SENSITIVE download Created with Sketch. 180.23KB
ZLD Ceasing to be a substantial holder
14/08/20 download Created with Sketch. 230.2KB
ZLD Change in substantial holding
14/08/20 download Created with Sketch. 160.53KB
ZLD Change of Director's Interest Notice x2
14/08/20 download Created with Sketch. 252.52KB
ZLD Notice of General Meeting
13/08/20 download Created with Sketch. 201.07KB
ZLD Letter to Shareholders re Upcoming General Meeting
13/08/20 download Created with Sketch. 167.25KB
ZLD Appendix 3G
11/08/20 download Created with Sketch. 319.74KB
ZLD Cleansing Notice and Appendix 2A
11/08/20 download Created with Sketch. 601.79KB
ZLD Proposed issue of Securities - ZLD
03/08/20 download Created with Sketch. 25.16KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed Placement
03/08/20PRICE SENSITIVE download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly Report
30/07/20PRICE SENSITIVE download Created with Sketch. 245.26KB
ZLD Trading Halt
29/07/20PRICE SENSITIVE download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular Diseases
22/07/20PRICE SENSITIVE download Created with Sketch. 224.23KB
ZLD Results of Meeting
21/07/20 download Created with Sketch. 254.05KB
ZLD Trading Halt
20/07/20PRICE SENSITIVE download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints
14/07/20PRICE SENSITIVE download Created with Sketch. 288.01KB
ZLD Proposed issue of Securities - ZLD
10/07/20 download Created with Sketch. 25.61KB
ZLD Director Performance Rights
10/07/20 download Created with Sketch. 152.67KB
ZLD Investor Presentation - Non-deal Roadshow
09/07/20 download Created with Sketch. 4.84MB
ZLD Proposed issue of Securities - ZLD
17/06/20 download Created with Sketch. 41.3KB
ZLD Notice of General Meeting
17/06/20 download Created with Sketch. 307.1KB
ZLD Letter to Shareholders
17/06/20 download Created with Sketch. 166.56KB
ZLD ZLD to form partnership for chronic pain in retired athletes
17/06/20 download Created with Sketch. 233.21KB
ZLD Finalisation of Appointment Details - Managing Director, USA
03/06/20 download Created with Sketch. 198.17KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE products
26/05/20PRICE SENSITIVE download Created with Sketch. 155.63KB
ZLD Investor Presentation - Non-deal Roadshow
01/05/20 download Created with Sketch. 5.08MB
ZLD Appendix 4C - quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly Report
30/04/20PRICE SENSITIVE download Created with Sketch. 162.06KB
ZLD Insomnia Phase 2 Clinical Trial Presentation
08/04/20 download Created with Sketch. 3.09MB
ZLD Zelira Therapeutics Insomnia Clinical Trial Media Release
07/04/20 download Created with Sketch. 307.83KB
ZLD Insomnia Trial Meets Primary and Secondary Endpoints
07/04/20PRICE SENSITIVE download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial Report
28/02/20PRICE SENSITIVE download Created with Sketch. 995.62KB
ZLD EMD: EMD to Conduct Opioid Sparing Clinical Trial for Zelira
27/02/20 download Created with Sketch. 195.36KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
38.0¢
Change
-0.030(7.32%)
Mkt cap ! $4.520M
Open High Low Value Volume
40.0¢ 42.0¢ 38.0¢ $1.766K 4.48K

Buyers (Bids)

No. Vol. Price($)
3 34234 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 5666 1
View Market Depth
Last trade - 15.50pm 15/09/2025 (20 minute delay) ?
Last
38.0¢
  Change
-0.030 ( 1.30 %)
Open High Low Volume
38.0¢ 38.0¢ 38.0¢ 1184
Last updated 14.55pm 15/09/2025 ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.